Alvaro has more than 10 years’ experience in Pharmaceutics spanning Industry and Academia, passionate about technology and health. He is one of the first researchers assessing opportunities of 3D printing using Fused Deposition Modeling (FDM) for manufacturing personalised oral dosage forms.
He is Co-Founder and Development Director of FabRx, a specialist biotech company, focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices.
Before moving to FabRx, he was a Postdoctoral Research Assistant at University College London - School of Pharmacy, manufacturing 3D printed medicines for oral drug delivery. His role included leading formulation development projects for pharmaceutical companies and managing research projects of MSc and Ph.D. students.
Prior to this, he got a fellowship from the Fundación Alfonso Martín Escudero for a Postdoctoral Research fellow in oral colon-specific delivery of vaccines at University College London- School of Pharmacy. Here he evaluated different approaches and technologies for colonic drug delivery through conventional methods and optimized biorelevant pharmaceutical dissolution testing.
Alvaro holds a PhD in Pharmaceutics from University of Santiago de Compostela (Spain) based on pelletization by extrusion-spheronization, and a degree in Pharmacy from the same university.